(WLK) Westlake Chemical - Ratings and Ratios
Ethylene, Polyethylene, PVC, Chlor-Alkali, Siding
WLK EPS (Earnings per Share)
WLK Revenue
Description: WLK Westlake Chemical November 03, 2025
Westlake Corporation (NYSE: WLK) operates two primary segments: Performance & Essential Materials, which produces ethylene-based chemicals such as polyethylene, PVC, and epoxy resins; and Housing & Infrastructure Products, which supplies a broad portfolio of PVC building components, roofing tiles, and specialty polymer compounds for construction, automotive, medical, and renewable-energy applications.
In FY 2023 the company reported adjusted EBITDA of roughly **$1.5 billion** and generated **free cash flow of $800 million**, supporting a **net debt-to-EBITDA ratio of 2.1×**, well below the industry median and indicative of solid balance-sheet flexibility.
Key economic drivers for Westlake include: (1) **PVC demand** that tracks U.S. residential-construction starts and municipal infrastructure spending, both of which have been buoyed by the recent $1.2 trillion bipartisan infrastructure law; (2) **ethylene margins** that are highly sensitive to natural-gas feedstock prices, which have averaged $2.30 /MMBtu in 2024, a level that compresses spreads relative to the 2022 peak; and (3) **global supply-chain tightening** in chlor-alkali and PVC intermediates, which has created a modest pricing premium for integrated producers like Westlake.
For a deeper, data-driven assessment of Westlake’s valuation and risk profile, you may find the analyst tools on ValueRay worth exploring further.
WLK Stock Overview
| Market Cap in USD | 8,825m |
| Sub-Industry | Commodity Chemicals |
| IPO / Inception | 2004-08-11 |
WLK Stock Ratings
| Growth Rating | -49.3% |
| Fundamental | 27.4% |
| Dividend Rating | 73.4% |
| Return 12m vs S&P 500 | -56.7% |
| Analyst Rating | 3.87 of 5 |
WLK Dividends
| Dividend Yield 12m | 3.15% |
| Yield on Cost 5y | 3.15% |
| Annual Growth 5y | 17.76% |
| Payout Consistency | 95.3% |
| Payout Ratio | 69.4% |
WLK Growth Ratios
| Growth Correlation 3m | -66% |
| Growth Correlation 12m | -83.1% |
| Growth Correlation 5y | 34.6% |
| CAGR 5y | -11.63% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.20 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.65 |
| Sharpe Ratio 12m | -2.35 |
| Alpha | -67.25 |
| Beta | 0.924 |
| Volatility | 49.01% |
| Current Volume | 874k |
| Average Volume 20d | 1167.1k |
| Stop Loss | 63.5 (-4.9%) |
| Signal | -0.55 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-957.0m TTM) > 0 and > 6% of Revenue (6% = 688.8m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -2.76pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 43.56% (prev 34.62%; Δ 8.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.03 (>3.0%) and CFO 674.0m > Net Income -957.0m (YES >=105%, WARN >=100%) |
| Net Debt (-1.18b) to EBITDA (483.0m) ratio: -2.44 <= 3.0 (WARN <= 3.5) |
| Current Ratio 7.67 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (128.3m) change vs 12m ago -0.84% (target <= -2.0% for YES) |
| Gross Margin 9.18% (prev 15.08%; Δ -5.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 56.11% (prev 57.44%; Δ -1.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -4.27 (EBITDA TTM 483.0m / Interest Expense TTM 159.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.95
| (A) 0.25 = (Total Current Assets 5.75b - Total Current Liabilities 750.0m) / Total Assets 19.81b |
| (B) 0.47 = Retained Earnings (Balance) 9.31b / Total Assets 19.81b |
| (C) -0.03 = EBIT TTM -679.0m / Avg Total Assets 20.46b |
| (D) 0.94 = Book Value of Equity 9.24b / Total Liabilities 9.88b |
| Total Rating: 3.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 27.36
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield -1.69% = -0.85 |
| 3. FCF Margin -1.10% = -0.41 |
| 4. Debt/Equity 0.08 = 2.50 |
| 5. Debt/Ebitda -2.44 = 2.50 |
| 6. ROIC - WACC (= -13.65)% = -12.50 |
| 7. RoE -9.42% = -1.57 |
| 8. Rev. Trend -75.25% = -5.64 |
| 9. EPS Trend -83.41% = -4.17 |
What is the price of WLK shares?
Over the past week, the price has changed by -12.64%, over one month by -18.26%, over three months by -11.86% and over the past year by -48.09%.
Is Westlake Chemical a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of WLK is around 50.86 USD . This means that WLK is currently overvalued and has a potential downside of -23.84%.
Is WLK a buy, sell or hold?
- Strong Buy: 6
- Buy: 1
- Hold: 8
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the WLK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 84.2 | 26.1% |
| Analysts Target Price | 84.2 | 26.1% |
| ValueRay Target Price | 57 | -14.6% |
WLK Fundamental Data Overview November 02, 2025
P/E Forward = 33.557
P/S = 0.7687
P/B = 0.9966
P/EG = 1.59
Beta = 0.924
Revenue TTM = 11.48b USD
EBIT TTM = -679.0m USD
EBITDA TTM = 483.0m USD
Long Term Debt = 4.56b USD (from longTermDebt, last fiscal year)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 750.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.18b USD (from netDebt column, last quarter)
Enterprise Value = 7.45b USD (8.82b + Debt 750.0m - CCE 2.12b)
Interest Coverage Ratio = -4.27 (Ebit TTM -679.0m / Interest Expense TTM 159.0m)
FCF Yield = -1.69% (FCF TTM -126.0m / Enterprise Value 7.45b)
FCF Margin = -1.10% (FCF TTM -126.0m / Revenue TTM 11.48b)
Net Margin = -8.34% (Net Income TTM -957.0m / Revenue TTM 11.48b)
Gross Margin = 9.18% ((Revenue TTM 11.48b - Cost of Revenue TTM 10.43b) / Revenue TTM)
Gross Margin QoQ = 8.32% (prev 8.74%)
Tobins Q-Ratio = 0.38 (Enterprise Value 7.45b / Total Assets 19.81b)
Interest Expense / Debt = 5.47% (Interest Expense 41.0m / Debt 750.0m)
Taxrate = -0.39% (negative due to tax credits) (3.00m / -775.0m)
NOPAT = -681.6m (EBIT -679.0m * (1 - -0.39%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 7.67 (Total Current Assets 5.75b / Total Current Liabilities 750.0m)
Debt / Equity = 0.08 (Debt 750.0m / totalStockholderEquity, last quarter 9.43b)
Debt / EBITDA = -2.44 (Net Debt -1.18b / EBITDA 483.0m)
Debt / FCF = 9.34 (negative FCF - burning cash) (Net Debt -1.18b / FCF TTM -126.0m)
Total Stockholder Equity = 10.16b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.83% (Net Income -957.0m / Total Assets 19.81b)
RoE = -9.42% (Net Income TTM -957.0m / Total Stockholder Equity 10.16b)
RoCE = -4.61% (EBIT -679.0m / Capital Employed (Equity 10.16b + L.T.Debt 4.56b))
RoIC = -4.54% (negative operating profit) (NOPAT -681.6m / Invested Capital 15.01b)
WACC = 9.11% (E(8.82b)/V(9.57b) * Re(9.42%) + D(750.0m)/V(9.57b) * Rd(5.47%) * (1-Tc(-0.00)))
Discount Rate = 9.42% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.03%
Fair Price DCF = unknown (Cash Flow -126.0m)
EPS Correlation: -83.41 | EPS CAGR: -34.28% | SUE: -1.04 | # QB: 0
Revenue Correlation: -75.25 | Revenue CAGR: -5.33% | SUE: -1.51 | # QB: 0
Additional Sources for WLK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle